Literature DB >> 19710295

Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.

Betty L Noel1, Sarit Lilo, Daniel Capurso, Jim Hill, James B Bliska.   

Abstract

Yersinia pestis, the agent of plague, uses a type III secretion injectisome to deliver Yop proteins into macrophages to counteract phagocytosis and induce apoptosis. Additionally, internalized Y. pestis can survive in the phagosomes of naïve or gamma interferon (IFN-gamma)-activated macrophages by blocking vacuole acidification. The Y. pestis LcrV protein is a target of protective antibodies. The binding of antibodies to LcrV at the injectisome tip results in neutralization of the apoptosis of Y. pestis-infected macrophages and is used as an in vitro correlate of protective immunity. The cytokines IFN-gamma and tumor necrosis factor alpha can cooperate with anti-LcrV to promote protection against lethal Y. pestis infection in mice. It is not known if these phagocyte-activating cytokines cooperate with anti-LcrV to increase the killing of the pathogen and decrease apoptosis in macrophages. We investigated how anti-LcrV and IFN-gamma impact bacterial survival and apoptosis in cultured murine macrophages infected with Y. pestis KIM5. Y. pestis KIM5 opsonized with polyclonal or monoclonal anti-LcrV was used to infect macrophages treated with or without IFN-gamma. The phagocytosis and survival of KIM5 and the apoptosis of macrophages were measured at different time points postinfection. The results show that anti-LcrV reduced apoptosis at an early time point (5 h) but not at a later time point (24 h). Polyclonal anti-LcrV was unable to inhibit apoptosis at either time point in IFN-gamma-activated macrophages. Additionally, anti-LcrV was ineffective at promoting the killing of KIM5 in naïve or activated macrophages. We conclude that Y. pestis can bypass protective antibodies to LcrV and activation with IFN-gamma to survive and induce apoptosis in murine macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710295      PMCID: PMC2756853          DOI: 10.1128/CVI.00172-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  48 in total

1.  The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.

Authors:  D S Black; J B Bliska
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

2.  A process for controlling intracellular bacterial infections induced by membrane injury.

Authors:  Deepannita Roy; David R Liston; Vincent J Idone; Anke Di; Deborah J Nelson; Céline Pujol; James B Bliska; Sabyasachi Chakrabarti; Norma W Andrews
Journal:  Science       Date:  2004-06-04       Impact factor: 47.728

3.  Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors.

Authors:  Gerd Prehna; Maya I Ivanov; James B Bliska; C Erec Stebbins
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

4.  Development of in vitro correlate assays of immunity to infection with Yersinia pestis.

Authors:  J Bashaw; S Norris; S Weeks; S Trevino; J J Adamovicz; S Welkos
Journal:  Clin Vaccine Immunol       Date:  2007-03-21

5.  The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis.

Authors:  Céline Pujol; James B Bliska
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

6.  Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function.

Authors:  Justin L Spinner; Jennifer A Cundiff; Scott D Kobayashi
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

7.  Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.

Authors:  R Nakajima; R R Brubaker
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase.

Authors:  J B Bliska; D S Black
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Lipopolysaccharide desensitization of macrophages provides protection against Yersinia enterocolitica-induced apoptosis.

Authors:  Klaus Ruckdeschel; Kathleen Richter
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 10.  Current challenges in the development of vaccines for pneumonic plague.

Authors:  Stephen T Smiley
Journal:  Expert Rev Vaccines       Date:  2008-03       Impact factor: 5.217

View more
  13 in total

Review 1.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

2.  A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system.

Authors:  Igor E Brodsky; Noah W Palm; Saheli Sadanand; Michelle B Ryndak; Fayyaz S Sutterwala; Richard A Flavell; James B Bliska; Ruslan Medzhitov
Journal:  Cell Host Microbe       Date:  2010-05-20       Impact factor: 21.023

3.  Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.

Authors:  Erin E Zwack; Eric M Feeley; Amanda R Burton; Baofeng Hu; Masahiro Yamamoto; Thirumala-Devi Kanneganti; James B Bliska; Jörn Coers; Igor E Brodsky
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

4.  Antibody Opsonization Enhances Early Interactions between Yersinia pestis and Neutrophils in the Skin and Draining Lymph Node in a Mouse Model of Bubonic Plague.

Authors:  Jeffrey G Shannon; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

5.  Insight into bacterial virulence mechanisms against host immune response via the Yersinia pestis-human protein-protein interaction network.

Authors:  Huiying Yang; Yuehua Ke; Jian Wang; Yafang Tan; Sebenzile K Myeni; Dong Li; Qinghai Shi; Yanfeng Yan; Hui Chen; Zhaobiao Guo; Yanzhi Yuan; Xiaoming Yang; Ruifu Yang; Zongmin Du
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

6.  Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.

Authors:  Anthony J Hickey; Jr-Shiuan Lin; Lawrence W Kummer; Frank M Szaba; Debra K Duso; Michael Tighe; Michelle A Parent; Stephen T Smiley
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

7.  Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague.

Authors:  Nicholas A Eisele; Hanni Lee-Lewis; Cynthia Besch-Williford; Charles R Brown; Deborah M Anderson
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

8.  Macrophage cell death upon intracellular bacterial infection.

Authors:  Xin-He Lai; Yunsheng Xu; Xiao-Ming Chen; Yi Ren
Journal:  Macrophage (Houst)       Date:  2015-04-26

9.  Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV.

Authors:  Maya I Ivanov; Jim Hill; James B Bliska
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

10.  Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague.

Authors:  Ami A Patel; Hanni Lee-Lewis; Jennifer Hughes-Hanks; Craig A Lewis; Deborah M Anderson
Journal:  PLoS Pathog       Date:  2012-07-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.